AVMA news
Monoclonal antibodies show promise as new therapy for veterinary patients
More than 100 monoclonal antibodies (mAb) designed to bind to specific target proteins are available for humans, including those intended to treat…
AVMA news
FDA approves first animal drug for Giardia duodenalis, additional drugs for cows, swine
The Food and Drug Administration (FDA) has recently approved a number of animal drugs, including those that treat Giardia duodenalis in dogs.
AVMA news
Conference of Research Workers in Animal Diseases – January 20-24, 2023
The Conference of Research Workers in Animal Diseases (CRWAD) held its annual conference from January 20-24 in Chicago. The CRWAD presented awards,…
AVMA news
Canine osteoarthritis drug, Lyme disease bacteria vaccine receive approvals
Two recent drug approvals mean a novel treatment for the control of canine osteoarthritis (OA) pain and an oral vaccine against the wildlife spread of…
AVMA news
Addressing global inequities in access to essential medicines
The World Veterinary Association (WVA) and the World Small Animal Veterinary Association (WSAVA) are taking steps to improve the global availability…
blog
AVMA endorses federal legislation to address illicit xylazine
The bill would equip law enforcement with additional tools to stop illegal xylazine trafficking while protecting veterinarians’ access to this…
blog
FDA proposes revisions to guidance on evaluating antimicrobial animal drugs
The FDA recently issued a draft update to guidance for industry (GFI) #152, which helps assess the risk of antimicrobial resistance in people from the…
AVMA news
FDA extends educational period for new policy on compounding animal drugs from bulk drug substances
The Food and Drug Administration has delayed enforcement of its finalized guidance regarding compounding animal drugs from bulk drug substances.
AVMA news
New listings in AVMA Animal Health Studies Database – August 2022
A new study in the AVMA Animal Health Studies Database looks at a gene’s enzymatic activity in dogs with immune thrombocytopenia to further…
AVMA news
Gene editing could create hypoallergenic cats
The allergen Fel d 1 shed by all cats is the primary cause of cat allergies in humans. Researchers used CRISPR editing to disrupt Fel d 1 genes in…
AVMA news
In Short - March 1, 2022
The FDA has approved drugs for pain in cats from osteoarthritis and surgery; Maddie’s pet challenge has been awarded a $7.4M grant, and the Auxiliary…
Compounding from bulk drug substances
Learn about GFI #256, which clarifies the circumstances under which FDA does not intend to pursue enforcement action for compounding animal drugs from…
AVMA news
A private practice teams up with the USDA to study drug use, resistance
Federal animal health authorities are working with a private veterinary services company to analyze the impact of antimicrobial administration on…
Over-the-counter antimicrobials changing to prescription-only
The FDA has outlined its process for changing certain medically important antimicrobial drugs from over-the-counter (OTC) to prescription (Rx). Rx…
AVMA news
Tailoring medicine by reading the code for life
Researchers in animal genetics indicate they have seen a profound influence of the Human Genome Project on animal medicine and comparative medicine in…
Compounding guidance for veterinarians
Learn about the regulatory parameters, quality control assurance, and practice considerations when using compounded products in veterinary medicine.
JAVMA news
Nevada veterinarians can treat patients with certain cannabis products
In October, licensed veterinarians in the Silver State can recommend and administer hemp and CBD products, yet many questions remain about the drug’s…
JAVMA news
People ingesting veterinary-use ivermectin in attempts to prevent, cure COVID-19
Health authorities are again warning people not to consume veterinary-use ivermectin products as poison control centers receive a surge in calls about…
JAVMA news
Academic groups seek easier approval path for gene-edited food animals
Two academic groups argue that the amount of regulatory oversight for genetic changes in food animals should depend on the nature of the changes, and…
JAVMA news
In video, FDA urges adverse event reporting
Whenever an animal drug is linked to an adverse event—in an animal or a person—Food and Drug Administration officials want to know about it.
JAVMA news
FDA wants to bring more antimicrobials under veterinarian control
Federal regulators plan to give veterinarians oversight of all animal uses of antimicrobials considered important for human medicine.
JAVMA news
Seresto collars come under greater scrutiny
Recent adverse event reports from pet owners related to a popular brand of flea and tick collars have gained national attention. The manufacturer has…
JAVMA news
Wisconsin announces inaugural alumni award winners
In 2019, the University of Wisconsin-Madison School of Veterinary Medicine Alumni Advisory Board launched an alumni awards program to recognize…
JAVMA news
Federal complex to expand animal disease studies, diagnostics
Dr. Kenneth R. Burton, coordinator of the National Bio- and Agro-Defense Facility, talked with JAVMA News about progress on the facility and how he…